U.S. Public Health Service (PHS) Rear Adm. Krista Pedley, who has led the federal 340B drug pricing program for more than a decade, has been promoted within the U.S. Health Resources and Services Administration (HRSA) in conjunction with a major HRSA overhaul. HRSA is expected soon to invite individuals to apply to be her successor as director of HRSA’s Office of Pharmacy Affairs (OPA), the HRSA unit that runs the 340B program.
Pedley has become Director of a new Office of Special Health Initiatives (OSHI) within the Office of the HRSA Administrator—making HRSA’s leader her new direct report. The change was effective Jan. 15, the same date as the broader HRSA overhaul. OSHI includes the 340B program plus HRSA’s vaccine injury compensation, global health, oral health, and behavioral health programs. HRSA’s Office of Women’s Health and Office of Health Equity “will work closely with this new office,” Tom Engels, whose last day as HRSA administrator was yesterday (see related story), said in a Jan. 15 email to the entire agency’s staff announcing the HRSA reshuffle.
U.S. Public Health Service (PHS) Rear Adm. Krista Pedley, who has led the federal 340B drug pricing program for more than a decade, has been promoted within the U.S. Health Resources and Services Administration (HRSA) in conjunction with a major HRSA overhaul. HRSA is expected soon to invite individuals to apply to be her successor as director of HRSA’s Office of Pharmacy Affairs (OPA), the HRSA unit that runs the 340B program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
